Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Nootropics Market , by Region, 2019-2027 (USD Billion)
1.2.2. Nootropics Market , by Distribution Channel, 2019-2027 (USD Billion)
1.2.3. Nootropics Market , by End Use , 2019-2027 (USD Billion)
1.2.4. Nootropics Market , by Product Type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nootropics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nootropics Market Dynamics
3.1. Nootropics Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing consumer spending on healthcare and wellness products
3.1.1.2. Growing awareness regarding the health benefits of the nootropics
3.1.2. Market Restraint
3.1.2.1. The high cost of the products and stringent regulatory framework
3.1.3. Market Opportunities
3.1.3.1. Newer technological innovations in the development of Nootropics Market
Chapter 4. Global Nootropics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Nootropics Market , by Distribution Channel
5.1. Market Snapshot
5.2. Global Nootropics Market by Distribution Channel, Performance - Potential Analysis
5.3. Global Nootropics Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
5.4. Nootropics Market , Sub Segment Analysis
5.4.1. Offline
5.4.2. Online
Chapter 6. Global Nootropics Market , by End Use
a. Market Snapshot
6.1. Global Nootropics Market by End Use, Performance - Potential Analysis
6.2. Global Nootropics Market Estimates & Forecasts by End Use 2018-2027 (USD Billion)
6.3. Nootropics Market , Sub Segment Analysis
6.3.1. Memory Enhancement
6.3.2. Mood & Depression
6.3.3. Sleep & Recovery
6.3.4. Longevity & Anti-aging
6.3.5. Attention & Focus
6.3.6. Anxiety
Chapter 7. Global Nootropics Market , by Product Type
b. Market Snapshot
7.1. Global Nootropics Market by Product Type, Performance - Potential Analysis
7.2. Global Nootropics Market Estimates & Forecasts by Product Type 2018-2027 (USD Billion)
7.3. Nootropics Market , Sub Segment Analysis
7.3.1. Racetams
7.3.2. Ampakines
7.3.3. Choline & Acetylcholine Intermediates
7.3.4. Synthetic B-Vitamin Derived Nootropics
7.3.5. Natural Nootropics
7.3.6. Peptide Nootropics
7.3.7. Smart Drugs
Chapter 8. Global Nootropics Market , Regional Analysis
8.1. Nootropics Market , Regional Market Snapshot
8.2. North America Nootropics Market
8.2.1. U.S. Nootropics Market
8.2.1.1. Distribution Channel breakdown estimates & forecasts, 2018-2027
8.2.1.2. End Use breakdown estimates & forecasts, 2018-2027
8.2.1.3. Product Type breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Nootropics Market
8.3. Europe Nootropics Market Snapshot
8.3.1. U.K. Nootropics Market
8.3.2. Germany Nootropics Market
8.3.3. France Nootropics Market
8.3.4. Spain Nootropics Market
8.3.5. Italy Nootropics Market
8.3.6. Rest of Europe Nootropics Market
8.4. Asia-Pacific Nootropics Market Snapshot
8.4.1. China Nootropics Market
8.4.2. India Nootropics Market
8.4.3. Japan Nootropics Market
8.4.4. Australia Nootropics Market
8.4.5. South Korea Nootropics Market
8.4.6. Rest of Asia Pacific Nootropics Market
8.5. Latin America Nootropics Market Snapshot
8.5.1. Brazil Nootropics Market
8.5.2. Mexico Nootropics Market
8.6. Rest of The World Nootropics Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. United Pharmacies
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. AlternaScript LLC
9.2.3. Cephalon, Inc.
9.2.4. Clarity Nootropics
9.2.5. Nootrobox, Inc.
9.2.6. Onnit Labs LLC
9.2.7. Peak Nootropics
9.2.8. Powder City LLC
9.2.9. Purelife Bioscience Co., Ltd
9.2.10. SupNootropic Biological Technology Co. Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption